Patent · US Active

Azapeptides as CD36 binding compounds

US8435954B2 · kind B2 · utility

1Cited by
0References
2Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 18, 2008
Grant dateMay 7, 2013
Priority date
Expiry dateOct 16, 2029

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/323
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An azapeptide derivative of growth hormone releasing peptide (GHRP) of Formula I: A-(Xaa)a-N(RA)—N(RB)—C(O)-(Xaa′)b-B which binds to CD 36.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.